Chemotherapy With the Ralox Regimen Combined With Anlotinib and Penpulimab for Unresectable Hepatocellular Carcinoma
Clinical trial NCT07746960 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07746960
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.